2370 On Other Exchanges
2370 is not on other exchanges.

medinet co ltd (2370) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDINET CO LTD (2370)

Related News

No related news articles were found.

medinet co ltd (2370) Related Businessweek News

No Related Businessweek News Found

medinet co ltd (2370) Details

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company offers manufacturing solutions for regenerative medical products/investigational products and specified cell products; and value chain solutions, including technology transfer and process development, quality control and assurance, logistics, etc. It provides various types of immuno-cell therapy, such as dendritic cell vaccine therapy, natural killer-cell therapy, gamma-delta T-cell therapy, alpha-beta T-cell therapy, and cytotoxic T-lymphocyte therapy. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was founded in 1995 and is headquartered in Yokohama, Japan.

170 Employees
Last Reported Date: 12/21/16
Founded in 1995

medinet co ltd (2370) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medinet co ltd
Medinet Co., Ltd. Reports Consolidated Earnings Results for the First Half Year Ended of March 2017; Provides Earnings Guidance for the Year Ending of September 2017

MEDINET Co., Ltd. reported consolidated earnings results for the first half year ended of March 2017. For the quarter, the company reported net sales of JPY 893 million compared to JPY 926 million a year ago. Operating loss was JPY 1,036 million compared to JPY 739 million a year ago. Ordinary loss was JPY 976 million compared to JPY 778 million a year ago. Loss attributable to owners of parent was JPY 991 million compared to JPY 791 million a year ago. Basic loss per share was JPY 10.70 compared to JPY 8.78 a year ago. Net cash used in operating activities was JPY 851,618,000 compared to JPY 410,973,000 a year ago. Purchase of property, plant and equipment was JPY 1,388,000 compared to JPY 9,237,000 a year ago. Purchase of intangible assets was JPY 14,460,000 compared to JPY 28,943,000 The company provided earnings guidance for the year ending of September 2017. For the period, the company expects net sales to be of JPY 2,250 million. Operating loss expected to be of JPY 1,967 million. Ordinary loss expected to be of JPY 1,951 million. Loss attributable to owners of parent expected to be of JPY 1,961 million. Basic loss per share expected to be of JPY 21.16.

MEDINET Co., Ltd., Q2 2017 Earnings Call, May 23, 2017

MEDINET Co., Ltd., Q2 2017 Earnings Call, May 23, 2017

MEDINET Co., Ltd. to Report Q2, 2017 Results on May 09, 2017

MEDINET Co., Ltd. announced that they will report Q2, 2017 results at 3:00 PM, Tokyo Standard Time on May 09, 2017


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2370 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2370.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2370 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.1x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDINET CO LTD, please visit www.medinet-inc.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.